This report was first published by Endpoints News. To see the original version, click here
On Nov. 19, Pfizer CFO Dave Denton said at the Jefferies Global Healthcare Conference that the large pharma was still looking for an oral small molecule for obesity and that it was looking in China.
On Dec. 9, Pfizer did exactly that.
您已閱讀22%（323字），剩余78%（1151字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。